Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT04654208
Swedish Ibrance Registries Insights (SIRI)
Sponsor: Pfizer
View on ClinicalTrials.gov
Summary
The main objectives of this study are to describe patient characteristics, treatment patterns and clinical outcomes of patients receiving palbociclib in Swedish clinical practice.
Official title: Palbociclib Treatment Patterns in Swedish Patients With Metastatic Breast Cancer - Swedish Ibrance Registries Insights (SIRI)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1500
Start Date
2020-12-15
Completion Date
2026-05-31
Last Updated
2026-03-31
Healthy Volunteers
No
Conditions
Interventions
DRUG
palbociclib
patients on palbociclib combination treatment
Locations (1)
Pfizer Sweden
Sollentuna, Sweden